ATC
AMGN icon

Advantage Trust Company’s Amgen AMGN Stock Holding History

Advantage Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17K Hold
6
– – ﹤0.01% 191
2026
Q1 		$2.11K Hold
6
– – ﹤0.01% 119
2025
Q4 		$1.96K Sell
6
-5
-45% -$1.59K ﹤0.01% 119
2025
Q3 		$3.1K Hold
11
– – ﹤0.01% 187
2025
Q2 		$3.07K Hold
11
– – ﹤0.01% 202
2025
Q1 		$3.43K Buy
+11
New +$3.25K ﹤0.01% 146

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Advantage Trust Company's AMGN Position: Q2 2026 in Review

Advantage Trust Company held its Amgen (AMGN) position steady in Q2 2026 at 6 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Advantage Trust Company first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.43K in Q1 2025. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advantage Trust Company held 6 shares of Amgen worth $2.17K as of Q2 2026.
  • Advantage Trust Company left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Advantage Trust Company's portfolio in Q2 2026, its #191 holding.
  • Advantage Trust Company first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Advantage Trust Company's Amgen position peaked at $3.43K in Q1 2025.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.